J Korean Pain Soc.  1995 Nov;8(2):272-278.

The Effect of Trigger Point Injection and C2-ganglion Block for the Patients with Chronic Headache

Affiliations
  • 1Neuropain Clinic, Department of Anesthesiology, College of Medicine, Inje University, Seoul, Korea.

Abstract

Headache is a common disease of the general population. But the main problem in any study of headache has been that of defining the disease entities. In 1988, the Headache Classification Committee of the International Headache Society introduced operational diagnostic criteria for all headache disorders into l3 major group; migraine, tension-type headache, cluster headache and chronic paroxysmal hemicrania etc. Sjaastad was the first to describe "cervicogenic headache", one of various head pain syndromes that probably originate in the cervical spine. Between March 1995 and June 1995, we studied 78 out-patients of the Department of Neuro pain clinic, Sanggye Paik Hospital, Inje university. We divided the patients into three study group fifty-three patients with tension-type headache, 13 with cervicogenic headache, and 12 with migraine headache. The reponse of trigger point injection and C2-ganglion block in patients was investigated. We paid particular attention to the response of trigger point injection in patients of the three group. The effect of trigger point injection was more marked in tension-type headache group than in the other categories. The pain reduction after C2-ganglion block was more marked in cervicogenic headache group than in the others.

Keyword

C2-ganglion block; Headache; Trigger point injection

MeSH Terms

Classification
Cluster Headache
Headache
Headache Disorders*
Humans
Migraine Disorders
Outpatients
Pain Clinics
Paroxysmal Hemicrania
Post-Traumatic Headache
Spine
Tension-Type Headache
Trigger Points*
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error